{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T04:20:42Z","timestamp":1787718042339,"version":"build-2784847793"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203308"],"award-info":[{"award-number":["NIHR203308"]}],"id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ero.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EULAR Rheumatology Open"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ero.2026.02.012","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T04:17:28Z","timestamp":1772511448000},"page":"289-296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["International IVIg prescription patterns in idiopathic inflammatory myopathies: real-world insights from the MyoNet survey"],"prefix":"10.1016","volume":"2","author":[{"given":"Kastriot","family":"Kastrati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latika","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B","family":"Lilleker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choon-Guan","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho","family":"So","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"New","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Lechner-Radner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Chinoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ero.2026.02.012_bib0001","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.mpmed.2024.09.005","article-title":"Adult idiopathic inflammatory myopathies","volume":"52","author":"Parker","year":"2024","journal-title":"Medicine"},{"key":"10.1016\/j.ero.2026.02.012_bib0002","doi-asserted-by":"crossref","DOI":"10.1111\/1756-185X.70295","article-title":"Classification in idiopathic inflammatory myopathies: where are we now?","volume":"28","author":"Shivakumar","year":"2025","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.ero.2026.02.012_bib0003","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/acr.24498","article-title":"Factors associated with treatment response in patients with idiopathic inflammatory myopathies: a registry-based study","volume":"74","author":"Espinosa-Ortega","year":"2022","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.ero.2026.02.012_bib0004","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s40674-018-0106-2","article-title":"Current treatment for myositis","volume":"4","author":"Barsotti","year":"2018","journal-title":"Curr Treatm Opt Rheumatol"},{"key":"10.1016\/j.ero.2026.02.012_bib0005","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrrheum.2018.42","article-title":"Treatment in myositis","volume":"14","author":"Oddis","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ero.2026.02.012_bib0006","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","article-title":"Idiopathic inflammatory myopathies","volume":"7","author":"Lundberg","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ero.2026.02.012_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102997","article-title":"Efficacy and safety of intravenous and subcutaneous immunoglobulin therapy in idiopathic inflammatory myopathy: a systematic review and meta-analysis","volume":"21","author":"Goswami","year":"2022","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ero.2026.02.012_bib0008","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMc1506163","article-title":"Intravenous immune globulin for statin-triggered autoimmune myopathy","volume":"373","author":"Mammen","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ero.2026.02.012_bib0009","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13075-019-2093-6","article-title":"Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patients","volume":"22","author":"Meyer","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ero.2026.02.012_bib0010","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa2117912","article-title":"Trial of intravenous immune globulin in dermatomyositis","volume":"387","author":"Aggarwal","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ero.2026.02.012_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102234","article-title":"Efficacy of intravenous immunoglobulins (IVIg) in improving skin symptoms in patients with dermatomyositis: a post-hoc analysis of the ProDERM study","volume":"64","author":"Werth","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ero.2026.02.012_bib0012","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s11926-023-01105-w","article-title":"Intravenous immunoglobulin in idiopathic inflammatory myopathies: a practical guide for clinical use","volume":"25","author":"Gandiga","year":"2023","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.ero.2026.02.012_bib0013","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/rheumatology\/keaa459","article-title":"Intravenous immunoglobulins as first-line treatment in idiopathic inflammatory myopathies: a pilot study","volume":"60","author":"Lim","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ero.2026.02.012_bib0014","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/rheumatology\/kead250","article-title":"Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study","volume":"63","author":"Ziade","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ero.2026.02.012_bib0015","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/rheumatology\/keac115","article-title":"British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy","volume":"61","author":"Oldroyd","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ero.2026.02.012_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2025.105902","article-title":"Health equity and causes of disparities in rheumatological management","volume":"92","author":"Dey","year":"2025","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.ero.2026.02.012_bib0017","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.ard.2025.07.010","article-title":"Global recruitment patterns and placebo responses in clinical trials of rheumatoid arthritis","volume":"84","author":"Kerschbaumer","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ero.2026.02.012_bib0018","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/art.43302","article-title":"Global recruiting patterns and placebo response rates in clinical trials of psoriatic arthritis and plaque psoriasis","volume":"78","author":"Kerschbaumer","year":"2026","journal-title":"Arthritis Rheumatol"}],"container-title":["EULAR Rheumatology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708126000297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708126000297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T03:53:07Z","timestamp":1787716387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050708126000297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S3050708126000297"],"URL":"https:\/\/doi.org\/10.1016\/j.ero.2026.02.012","relation":{},"ISSN":["3050-7081"],"issn-type":[{"value":"3050-7081","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"International IVIg prescription patterns in idiopathic inflammatory myopathies: real-world insights from the MyoNet survey","name":"articletitle","label":"Article Title"},{"value":"EULAR Rheumatology Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ero.2026.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}